Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL5314801

IDRAPARINUX
🧪 Phase III
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
🧪 Phase III
CO[C@H]1O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](C(=O)O)[C@@H](O[C@H]3O[C@H](COS(=O)(=O)O)[C@@H](O[C@@H]4O[C@H](C(=O)O)[C@@H](O[C@H]5O[C@H](COS(=O)(=O)O)[C@@H](OC)[C@H](OC)[C@H]5OC)[C@H](OC)[C@H]4OC)[C@H](OS(=O)(=O)O)[C@H]3OS(=O)(=O)O)[C@H](OC)[C@H]2OC)[C@H](OS(=O)(=O)O)[C@H]1OS(=O)(=O)O

Basic Information

ChEMBL ID CHEMBL5314801
Name IDRAPARINUX
Phase Phase III
Structure Type MOL
InChI Key AJBMORBNKXNZSF-COSHMZDQSA-N

Known Names

Idraparinux SR 34006 SR-34006 Sr34006
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
4
Known Names
1
Indications

Molecular Properties

1529.3
MW (Da)

Drug Information

Molecule Type Oligosaccharide
Chirality Single Enantiomer
USAN Stem -parinux
USAN Year 2004

Extended Properties

Molecular Formula C38H64O49S7
MW 1529.35

Indications

Pulmonary Embolism

Data from ChEMBL 36 via Core Engine